Work

Supplementary Figure 5 from Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 5 from Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy

DOI: 10.1158/0008-5472.22386828.v1

Authors: Guillaume Ploussard, Stéphane Terry, Pascale Maillé, Yves Allory, Nanor Sirab, Laurence Kheuang, Pascale Soyeux, Nathalie Nicolaiew, Estelle Coppolani, Bernard Paule, Laurent Salomon, Stéphane Culine, Ralph Buttyan, Francis Vacherot, Alexandre de la Taille

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362417158

Cites:

Cited by:

Related to: 10